Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17399
Country/Region: Zambia
Year: 2016
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $10,352,512 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $100,000
Care: TB/HIV (HVTB) $784,000
Care: Pediatric Care and Support (PDCS) $198,546
Laboratory Infrastructure (HLAB) $1,023,900
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $2,523,992
Testing: HIV Testing and Counseling (HVCT) $1,239,100
Sexual Prevention: Other Sexual Prevention (HVOP) $500,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $500,000
Treatment: Adult Treatment (HTXS) $3,250,000
Treatment: Pediatric Treatment (PDTX) $232,974
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 1,560
HTS_TST Age/sex: 1-9 2017 10,970
HTS_TST Age/sex: 10-14 Female 2017 2,411
HTS_TST Age/sex: 10-14 Male 2017 2,412
HTS_TST Age/sex: 15-19 Female 2017 2,135
HTS_TST Age/sex: 15-19 Male 2017 2,136
HTS_TST Age/sex: 20-24 Female 2017 1,930
HTS_TST Age/sex: 20-24 Male 2017 1,928
HTS_TST Age/sex: 25-49 Female 2017 5,343
HTS_TST Age/sex: 25-49 Male 2017 5,348
HTS_TST Age/sex: 50+ Female 2017 1,420
HTS_TST Age/sex: 50+ Male 2017 1,407
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 33,076
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 33,179
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 43,716
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 42,029
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 152,000
HTS_TST Service Delivery Point (Facility): Outpatient 2017 103,117
HTS_TST Service Delivery Point (Facility): PMTCT 2017 7,583
HTS_TST Service Delivery Point (Facility): VMMC 2017 41,300
HTS_TST Sum of Age/Sex disaggregates 2017 26,470
HTS_TST Sum of Aggregated Age/Sex <15 2017 66,255
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 85,745
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 152,000
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 313
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 313
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 278
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 278
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 251
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 251
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 695
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 696
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 184
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 183
HTS_TST_POS Test Result by Age: Positive: <1 2017 202
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 1,426
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 4,298
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 4,313
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 5,681
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 5,261
PMTCT_ART Already on ART at beginning of current pregnancy 2017 90
PMTCT_ART New on ART 2017 861
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 8,208
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 857
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 94
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 3
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 43
PMTCT_EID Sum of Infant Age disaggregates 2017 951
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 115
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 33
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 33
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 91
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 17
PMTCT_STAT By: Known positives at entry 2017 143
PMTCT_STAT By: Number of new positives identified 2017 1,327
PMTCT_STAT Number of new ANC and L&D clients 2017 15,189
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 8,208
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 11
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 8
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 105
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 29
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 29
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 84
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 16
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,470
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 950
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 261
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 261
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 760
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 143
PP_PREV Aggregated Age/sex: 15+ Female 2017 94,705
PP_PREV Aggregated Age/sex: 15+ Male 2017 105,295
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 200,000
PP_PREV Total number of people in the target population 2017 1,277,945
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,298
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,298
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,398
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 5,937
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 5,706
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 4,492
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 4,505
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 20,640
TX_CURR Age/Sex: <1 2017 282
TX_CURR Age/Sex: <1-9 2017 1,979
TX_CURR Age/Sex: 10-14 Female 2017 434
TX_CURR Age/Sex: 10-14 Male 2017 434
TX_CURR Age/Sex: 15-19 Female 2017 385
TX_CURR Age/Sex: 15-19 Male 2017 385
TX_CURR Age/Sex: 20-24 Female 2017 351
TX_CURR Age/Sex: 20-24 Male 2017 344
TX_CURR Age/Sex: 25-49 Female 2017 1,189
TX_CURR Age/Sex: 25-49 Male 2017 1,031
TX_CURR Age/Sex: 50+ Female 2017 256
TX_CURR Age/Sex: 50+ Male 2017 256
TX_CURR Aggregated Age/Sex: <15 Female 2017 4,580
TX_CURR Aggregated Age/Sex: <15 Male 2017 4,573
TX_CURR Aggregated Age/Sex: 15+ Female 2017 9,404
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,534
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 26,092
TX_CURR Sum of age/sex disaggregates 2017 770
TX_CURR Sum of Aggregated Age/Sex <15 2017 9,153
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 16,938
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 26,091
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 4,045
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 4,059
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 5,345
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 5,141
TX_NEW By Age/Sex: <1 2017 202
TX_NEW By Age/Sex: 1-9 2017 1,428
TX_NEW By Age/Sex: 10-14 Female 2017 313
TX_NEW By Age/Sex: 10-14 Male 2017 313
TX_NEW By Age/Sex: 15-19 Female 2017 278
TX_NEW By Age/Sex: 15-19 Male 2017 278
TX_NEW By Age/Sex: 20-24 Female 2017 250
TX_NEW By Age/Sex: 20-24 Male 2017 250
TX_NEW By Age/Sex: 25-49 Female 2017 695
TX_NEW By Age/Sex: 25-49 Male 2017 695
TX_NEW By Age/Sex: 50+ Female 2017 184
TX_NEW By Age/Sex: 50+ Male 2017 184
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 18,590
TX_NEW Sum of Age/Sex disaggregates 2017 3,440
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 18,590
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 32,299
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 8,076
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,779
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,778
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,300
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,219
TX_PVLS Numerator: Indication: Routine 2017 8,076
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 7,028
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 7,052
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 9,288
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 8,931
TX_PVLS_den Denominator: Indication: Routine 2017 32,299
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 68
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 482
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 105
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 105
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 93
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 94
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 87
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 84
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 234
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 234
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 63
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 62
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,365
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,367
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,804
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,737
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 6,273
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 7,090
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 78
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 544
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 118
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 119
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 105
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 106
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 98
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 266
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 264
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 71
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 70
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,930
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,937
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,553
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,455
VMMC_CIRC By Age: 0-60 days 2017 1,483
VMMC_CIRC By Age: 10-14 2017 18,552
VMMC_CIRC By Age: 15-19 2017 18,552
VMMC_CIRC By Age: 20-24 2017 14,840
VMMC_CIRC By Age: 25-29 2017 14,841
VMMC_CIRC By Age: 30-49 2017 5,195
VMMC_CIRC By Age: 50+ 2017 742
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 74,199
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 74,199
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 72,722
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 52,686
Cross Cutting Budget Categories and Known Amounts Total: $50,000
Water $50,000